絞り込み

16555

広告

Net Clinical Benefit of Edoxaban for Stroke, Mortality, and Bleeding Risk: Modeling Projections for a European Population.

著者 Blann AD , Pisters R , Lip GYH
JACC Clin Electrophysiol.2016 Feb ; 2(1):47-54.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (71view , 0users)

Full Text Sources

Miscellaneous

The purpose of this study was to determine, in a model based on Europeans at risk of stroke by virtue of atrial fibrillation (AF), the net clinical benefit of edoxaban in the reduction of the risk of stroke, mortality, and of hemorrhage.
PMID: 29766853 [PubMed]
印刷用ページを開く Endnote用テキストダウンロード